Jessica Li
About Jessica Li
Jessica Li is the Associate Director of CAR-T Access Marketing for Abecma at Bristol Myers Squibb, with extensive experience in cell therapy marketing and patient support programs.
Title and Current Role
Jessica Li currently holds the position of Associate Director, CAR-T Access Marketing, Abecma at Bristol Myers Squibb. In this role, she leads the launch strategy for Abecma, a CAR-T cell therapy.
Previous Experience at Iovance Biotherapeutics
Jessica Li worked at Iovance Biotherapeutics, Inc. where she served as Director, Cell Therapy Hub & Patient Support for four months in 2022. Before that, she was the Associate Director, Cell Therapy Hub & Patient Support from 2020 to 2022, focusing on patient support and cell therapy marketing.
Early Career Roles
Jessica Li has held various roles in the biotech and pharmaceutical industries. She was a Senior Associate at PwC in the San Francisco Bay Area from 2018 to 2020. Additionally, she has had internship experiences at Pharmacyclics and Genentech, and served as an Analyst at GfK Market Access and Scientia Advisors.
Educational Background
Jessica Li holds a Master of Business Administration (MBA) from Duke University's Fuqua School of Business, with a focus on Health Sector Management. She also earned a Bachelor of Science (BS) in Biological Engineering from the Massachusetts Institute of Technology (MIT).
Specialization in Cell Therapy and Market Access
Jessica Li specializes in cell therapy marketing and has a strong background in market access strategies for CAR-T therapies. Her role at Bristol Myers Squibb and previous experience at Iovance Biotherapeutics have equipped her with extensive knowledge in this area.
Research and Academic Contributions
During her undergraduate studies at MIT, Jessica made significant contributions to research conducted at the Griffith Lab. She was involved in various projects as an undergraduate researcher from 2011 to 2013.